These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Long-term incidence of febrile UTI after DxHA treatment of VUR. Fotso Kamdem A, Galli G, Aubert D. J Pediatr Urol; 2014 Feb; 10(1):56-61. PubMed ID: 23810062 [Abstract] [Full Text] [Related]
6. Randomized clinical trial between polyacrylate-polyalcohol copolymer (PPC) and dextranomer-hyaluronic acid copolymer (Dx/HA) as bulking agents for endoscopic treatment of primary vesicoureteral reflux (VUR). García-Aparicio L, Blázquez-Gómez E, Martin O, Pérez-Bertólez S, Arboleda J, Soria A, Tarrado X. World J Urol; 2018 Oct; 36(10):1651-1656. PubMed ID: 29725806 [Abstract] [Full Text] [Related]
7. Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: the Children's Hospitals of Atlanta experience. Kirsch AJ, Perez-Brayfield MR, Scherz HC. J Urol; 2003 Jul; 170(1):211-5. PubMed ID: 12796692 [Abstract] [Full Text] [Related]
8. Proprietary non-animal stabilized hyaluronic acid/dextranomer gel (NASHA/Dx) for endoscopic treatment of grade IV vesicoureteral reflux: Long-term observational study. Stenbäck A, Olafsdottir T, Sköldenberg E, Barker G, Stenberg A, Läckgren G. J Pediatr Urol; 2020 Jun; 16(3):328.e1-328.e9. PubMed ID: 32414615 [Abstract] [Full Text] [Related]
9. Routine delayed voiding cystourethography after initial successful endoscopic treatment with Dextranomer/Hialuronic Acid Copolimer (Dx/HA) of vesicoureteral reflux (VUR). Is it necessary? García-Aparicio L, Blázquez-Gómez E, Vila Santandreu A, Camacho Diaz JA, Vila-Cots J, Ramos Cebrian M, de Haro I, Martin O, Tarrado X. Actas Urol Esp; 2016 Dec; 40(10):635-639. PubMed ID: 27161091 [Abstract] [Full Text] [Related]
10. Endoscopic hyaluronic acid/dextranomer gel implantation is effective as first-line treatment of vesicoureteral reflux (VUR) in children: a single centre experience. Häcker FM, Frech-Dörfler M, von Rotz M, Rudin C. Eur J Pediatr Surg; 2011 Oct; 21(5):299-303. PubMed ID: 21688236 [Abstract] [Full Text] [Related]
11. Prospective comparison and 1-year follow-up of a single endoscopic subureteral polydimethylsiloxane versus dextranomer/hyaluronic acid copolymer injection for treatment of vesicoureteral reflux in children. Oswald J, Riccabona M, Lusuardi L, Bartsch G, Radmayr C. Urology; 2002 Nov; 60(5):894-7; discussion 898. PubMed ID: 12429323 [Abstract] [Full Text] [Related]
12. Part 3: Endoscopic injection versus antibiotic prophylaxis in the reduction of urinary tract infections in patients with vesicoureteral reflux. Elder JS, Shah MB, Batiste LR, Eaddy M. Curr Med Res Opin; 2007 Sep; 23 Suppl 4():S15-20. PubMed ID: 17931480 [Abstract] [Full Text] [Related]
13. Clinical value of persistent but downgraded vesicoureteral reflux after dextranomer/hyaluronic acid injection in children. Baek M, Kang MY, Lee HE, Park K, Choi H. J Korean Med Sci; 2013 Jul; 28(7):1060-4. PubMed ID: 23853490 [Abstract] [Full Text] [Related]
18. Retrospective study of endoscopic treatment in children with primary vesicoureteral reflux and multivariate analysis of factors for failure. Akin Y, Gulmez H, Güntekin E, Baykara M, Yucel S. Scand J Urol; 2014 Dec; 48(6):565-70. PubMed ID: 25028806 [Abstract] [Full Text] [Related]